Bacteriophages: potential treatment for bacterial infections

Area of Science:

• Microbiology
• Virology
• Infectious Diseases

Background:

• Bacteriophages (phages) were initially used to treat bacterial infections but research ceased in the West due to issues with early studies and the advent of antibiotics.
• Research and clinical use of phages continued in Eastern Europe for human infections.
• The rise of antibacterial resistance has prompted a re-evaluation of phage therapy.

Purpose of the Study:

• To review historical phage therapy studies.
• To initiate controlled experiments in animal models to assess phage efficacy.
• To evaluate the potential of phage therapy in combating bacterial infections, particularly in the context of antibiotic resistance.

Main Methods:

• Review of Eastern European phage therapy studies.
• Initiation of controlled experiments using animal models.
• Assessment of phage characteristics such as lethality, specificity, replication ability, and safety.

Main Results:

• Recent controlled studies confirm the high efficacy of phages in treating various bacterial infections.
• Phages demonstrate specific targeting of bacteria, ability to replicate within hosts, and a favorable safety profile.
• Phage therapy shows significant potential as an antibacterial agent.

Conclusions:

• Phage therapy is an efficacious antibacterial agent due to its lethality, specificity, replication ability, and safety.
• Despite remaining challenges, phage therapy is likely to be reintegrated into medical and veterinary practices.
• Phage therapy offers a viable alternative for treating infectious diseases amidst growing antibacterial resistance.